Invited Abstract 9th Australasian Vaccines & Immunotherapeutics Development Meeting 2022

COVID-19 vaccines and variants: studies from Singapore (#10)

Barnaby Young 1
  1. National Centre for Infectious Diseases, Singapore, SINGAPORE

A key part of Singapore’s response to the COVID-19 pandemic was two large national observational studies (PROTECT & SCOPE). These studies aimed to provide policy makers with clinical, virological and immunological data to guide decisions. In this talk the findings from these studies, and how the study questions evolved with the epidemiology of the pandemic will be presented.